<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01823497</url>
  </required_header>
  <id_info>
    <org_study_id>FP4155</org_study_id>
    <nct_id>NCT01823497</nct_id>
  </id_info>
  <brief_title>Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit</brief_title>
  <acronym>PNCA</acronym>
  <official_title>Parent/Nurse Controlled Analgesia for Post-Operative Pain Management in Neonates: A Preliminary Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Children's Hospital and Health System Foundation, Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine the safety and effectiveness of 2 morphine delivery&#xD;
      systems for post-surgical neonates. The investigators hypothesize that this study will be&#xD;
      feasible to conduct, and that neonates receiving morphine via a Parent/Nurse Controlled&#xD;
      Analgesia pump will receive less morphine and experience fewer side effects than neonates&#xD;
      receiving morphine via continuous opioid infusion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">March 2019</completion_date>
  <primary_completion_date type="Actual">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Morphine Consumption</measure>
    <time_frame>5 days post surgery</time_frame>
    <description>The investigators will measure amount of morphine consumed post-surgery in mg/kg/hour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Revised-Face, Legs, Activity, Cry, Consolability (Revised-FLACC) Scale</measure>
    <time_frame>4 days post surgery</time_frame>
    <description>The investigators will report the average pain score per POD, for 4 days (PODs 0,1,2,3). Higher scores mean worse outcome. Good pain control will be defined as pain less than 4 on a 0-10 scale. Pain is scored by observers on a minimum of 0 (no pain) to a maximum of 10 (worst pain) on this scale. The median and inter-quartile range of the average pain score per post-operative day is reported. The timeframe includes the post-operative day (POD 0), and 3 days post-surgery (POD 1-3), for a total of 4 post-operative days.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Methadone Use</measure>
    <time_frame>up to 3 days after morphine is discontinued</time_frame>
    <description>Methadone will serve as a surrogate for tolerance and will be monitored up to 3 days after the morphine has been discontinued.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Abdominal Surgery</condition>
  <condition>Thoracic Surgery</condition>
  <arm_group>
    <arm_group_label>Parent/Nurse Controlled Analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Parent/Nurse Controlled Analgesia will be the method of morphine delivery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous Opioid Infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous Opioid Infusion will be the method used to deliver morphine to group 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine</intervention_name>
    <description>Morphine will be used to control pain post-surgery.</description>
    <arm_group_label>Continuous Opioid Infusion</arm_group_label>
    <arm_group_label>Parent/Nurse Controlled Analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Surgery Location:&#xD;
&#xD;
               -  Abdominal or Thoracic&#xD;
&#xD;
               -  First surgery only&#xD;
&#xD;
        Age:&#xD;
&#xD;
          -  Born ≥ 34-44 weeks post-menstrual age&#xD;
&#xD;
          -  Weight: Weight at birth or current weight ≥2 kg Intubated or extubated&#xD;
&#xD;
        Prior opioid exposure:&#xD;
&#xD;
          -  &lt; 2 days of continuous exposure&#xD;
&#xD;
          -  if history of &gt; 2 day continuous exposure, must be off continuous drip for a week&#xD;
&#xD;
          -  Intermittent exposure ≤ 2 days prior to surgery Neonates exposed to chronic opioids in&#xD;
             utero *In utero exposure to Selective Seretonin Reuptake Inhibitors and illicit drugs&#xD;
             will be screened for and annotated.&#xD;
&#xD;
        At least 1 parent is English-speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Surgery Type:&#xD;
&#xD;
               -  Cardiac, Patent Ductus Arteriosus Ligation; Omphalocele (if intubated&#xD;
                  pre-operatively)&#xD;
&#xD;
        Diagnoses:&#xD;
&#xD;
        • Necrotizing Enterocolitis; Diaphragmatic hernia (unless thoracoscopically repaired);&#xD;
        Chemically or physiologically paralyzed Receiving vasopressors Receiving acetaminophen or a&#xD;
        benzodiazepine (lorazepam or midazolam) ≤ 24 h before surgery Patients with any of the&#xD;
        following: Epidural; Oscillating ventilator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>70 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keri R Hainsworth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michelle L Czarnecki, MSN RN-BC CPNP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital and Health System Foundation, Wisconsin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>March 29, 2013</study_first_submitted>
  <study_first_submitted_qc>April 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <results_first_submitted>July 8, 2020</results_first_submitted>
  <results_first_submitted_qc>August 31, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 2, 2020</results_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neonatal Intensive Care Unit</keyword>
  <keyword>neonate</keyword>
  <keyword>pain</keyword>
  <keyword>morphine</keyword>
  <keyword>Parent/Nurse Controlled Analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 7, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/97/NCT01823497/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Parent/Nurse Controlled Analgesia</title>
          <description>Parent/Nurse Controlled Analgesia will be the method of morphine delivery.&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
        </group>
        <group group_id="P2">
          <title>Continuous Opioid Infusion</title>
          <description>Continuous Opioid Infusion will be the method used to deliver morphine to group 2&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Parent/Nurse Controlled Analgesia</title>
          <description>Parent/Nurse Controlled Analgesia will be the method of morphine delivery.&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
        </group>
        <group group_id="B2">
          <title>Continuous Opioid Infusion</title>
          <description>Continuous Opioid Infusion will be the method used to deliver morphine to group 2&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4" lower_limit="1.3" upper_limit="12.0"/>
                    <measurement group_id="B2" value="2" lower_limit="0.0" upper_limit="59.0"/>
                    <measurement group_id="B3" value="4" lower_limit="2.0" upper_limit="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Morphine Consumption</title>
        <description>The investigators will measure amount of morphine consumed post-surgery in mg/kg/hour</description>
        <time_frame>5 days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parent/Nurse Controlled Analgesia</title>
            <description>Parent/Nurse Controlled Analgesia will be the method of morphine delivery.&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Opioid Infusion</title>
            <description>Continuous Opioid Infusion will be the method used to deliver morphine to group 2&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Morphine Consumption</title>
          <description>The investigators will measure amount of morphine consumed post-surgery in mg/kg/hour</description>
          <units>mg/kg/hr</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.014" lower_limit="0.013" upper_limit="0.017"/>
                    <measurement group_id="O2" value="0.036" lower_limit="0.036" upper_limit="0.040"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Revised-Face, Legs, Activity, Cry, Consolability (Revised-FLACC) Scale</title>
        <description>The investigators will report the average pain score per POD, for 4 days (PODs 0,1,2,3). Higher scores mean worse outcome. Good pain control will be defined as pain less than 4 on a 0-10 scale. Pain is scored by observers on a minimum of 0 (no pain) to a maximum of 10 (worst pain) on this scale. The median and inter-quartile range of the average pain score per post-operative day is reported. The timeframe includes the post-operative day (POD 0), and 3 days post-surgery (POD 1-3), for a total of 4 post-operative days.</description>
        <time_frame>4 days post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Parent/Nurse Controlled Analgesia</title>
            <description>Parent/Nurse Controlled Analgesia will be the method of morphine delivery.&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
          </group>
          <group group_id="O2">
            <title>Continuous Opioid Infusion</title>
            <description>Continuous Opioid Infusion will be the method used to deliver morphine to group 2&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
          </group>
        </group_list>
        <measure>
          <title>Revised-Face, Legs, Activity, Cry, Consolability (Revised-FLACC) Scale</title>
          <description>The investigators will report the average pain score per POD, for 4 days (PODs 0,1,2,3). Higher scores mean worse outcome. Good pain control will be defined as pain less than 4 on a 0-10 scale. Pain is scored by observers on a minimum of 0 (no pain) to a maximum of 10 (worst pain) on this scale. The median and inter-quartile range of the average pain score per post-operative day is reported. The timeframe includes the post-operative day (POD 0), and 3 days post-surgery (POD 1-3), for a total of 4 post-operative days.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-operative Day 0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.25" lower_limit="0.43" upper_limit="2.81"/>
                    <measurement group_id="O2" value="1.67" lower_limit="0.00" upper_limit="4.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-operative Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.79" lower_limit="1.37" upper_limit="2.55"/>
                    <measurement group_id="O2" value="1.083" lower_limit="0.00" upper_limit="3.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-operative Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.17" lower_limit="0.31" upper_limit="2.36"/>
                    <measurement group_id="O2" value="1.83" lower_limit="0.58" upper_limit="3.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-operative Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.00" lower_limit="0.00" upper_limit="2.44"/>
                    <measurement group_id="O2" value="1.25" lower_limit="0.31" upper_limit="2.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Methadone Use</title>
        <description>Methadone will serve as a surrogate for tolerance and will be monitored up to 3 days after the morphine has been discontinued.</description>
        <time_frame>up to 3 days after morphine is discontinued</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected up to 3 post-operative days</time_frame>
      <desc>The intervention involved in this study would not be associated with all-cause mortality</desc>
      <group_list>
        <group group_id="E1">
          <title>Parent/Nurse Controlled Analgesia</title>
          <description>Parent/Nurse Controlled Analgesia will be the method of morphine delivery.&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
        </group>
        <group group_id="E2">
          <title>Continuous Opioid Infusion</title>
          <description>Continuous Opioid Infusion will be the method used to deliver morphine to group 2&#xD;
Morphine: Morphine will be used to control pain post-surgery.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Naloxone, reintubation, or methadone</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Sedation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="16"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Keri R. Hainsworth</name_or_title>
      <organization>Medical College of Wisconsin</organization>
      <phone>414-266-6306</phone>
      <email>khainswo@mcw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

